CELESBITAN 1 FA C/JER 8MG/2 ML STREGER T- 38 % Tratamiento de anemia asociada a

Description

Tratamiento de anemia asociada a insuficiencia renal crónica

Prevención de progresión tumoral mediante inhibición de la angiogénesis

PRINCIPIO ACTIVO: MOXIFLOXACINO

PRINCIPIO ACTIVO: BIOFLANIDES

hipercalemia

CELESBITAN 1 FA C/JER 8MG/2 ML STREGER T- 38 % Tratamiento de anemia asociada aBETAMETASONA 8. 00 MG

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy